Life Science Company News

Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Eagle Pharmaceuticals and Enalare Therapeutics Announce Additional Award Worth Up to $50 Million from BARDA to Advance an Intramuscular (“IM”) Formulation of ENA-001

Read more ››
By: GlobenewsWire - 27 Sep 2022

Voyager Therapeutics to Participate in Upcoming Investor Conferences

Read more ››
By: GlobenewsWire - 27 Sep 2022

NMD Pharma receives Orphan Drug Designation from FDA for NMD670 for the Treatment of Myasthenia Gravis

Read more ››
By: GlobenewsWire - 27 Sep 2022

Aquestive Therapeutics Announces Positive EPIPHAST II Trial Data for AQST-109 When Compared to EpiPen®

Read more ››
By: GlobenewsWire - 27 Sep 2022

BioRestorative Therapies to Participate in the Roth Inaugural Healthcare Opportunities Conference

Read more ››
By: GlobenewsWire - 27 Sep 2022

Aclaris Therapeutics Appoints Robert Doody as Vice President, Investor Relations

Read more ››
By: GlobenewsWire - 27 Sep 2022

Clearside Biomedical to Present Corporate Overview and Upcoming Catalysts at Eyecelerator at the American Academy of Ophthalmology (AAO) 2022 Annual Meeting

Read more ››
By: GlobenewsWire - 27 Sep 2022

Entourage Launches Unique Medical Cannabis Marketplace “Syndicate” Offering Premium Craft Products From Collective of In-House and Third-Party Micro Producers

Read more ››
By: GlobenewsWire - 27 Sep 2022

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Read more ››
By: GlobenewsWire - 27 Sep 2022

Opus Genetics Expands Board of Directors with Appointment of Global Ophthalmology Leader Dr. Adrienne Graves

Read more ››
By: GlobenewsWire - 27 Sep 2022

IN8bio to Present at Cantor Oncology & HemOnc Conference

Read more ››
By: GlobenewsWire - 27 Sep 2022

Tavros Therapeutics Raises $7.5 Million in Oversubscribed Seed II Round

Read more ››
By: GlobenewsWire - 27 Sep 2022

Context Therapeutics® Amends Cash Guidance, Extends Runway into Q1 2024

Read more ››
By: GlobenewsWire - 27 Sep 2022

Dyne Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference

Read more ››
By: GlobenewsWire - 27 Sep 2022

Cognition Therapeutics Awarded $2.14 Million in Supplemental Grant Funding from NIA to Support SEQUEL Clinical Trial

Read more ››
By: GlobenewsWire - 27 Sep 2022

X4 Pharmaceuticals Announces New Positive Phase 1b Data Supporting Mavorixafor’s Broad Potential in Chronic Neutropenia (CN)

Read more ››
By: GlobenewsWire - 27 Sep 2022

Payment Integrity Leader CERIS Promotes Two Executives to Senior Management Roles

Read more ››
By: GlobenewsWire - 27 Sep 2022

atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01

Read more ››
By: GlobenewsWire - 27 Sep 2022

Ovid Therapeutics to Present at the Ladenburg Thalmann 2022 Healthcare Conference

Read more ››
By: GlobenewsWire - 27 Sep 2022

aTyr Pharma Announces Dosing of First Patient in Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis

Read more ››
By: GlobenewsWire - 27 Sep 2022
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate